18.02.2013 Views

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Many of the constituents in both the gas phase <strong>and</strong> the particulate phase of smoke<br />

paralyse the cilia lining the airways. Cilia are the hair-like structures on the surface of<br />

airway cells that rhythmically beat to move mucus up <strong>and</strong> out of the lung aiding in the<br />

removal of particles deposited on the surface of the airways. Paralysis interferes<br />

with the clearance process of the lung <strong>and</strong> results in a longer residence time in the<br />

airway for toxic smoke constituents. Lastly, smoke can oxidatively inactivate some<br />

of the protective proteins in the blood, most notably the antiproteases that prevent<br />

lung digestion.<br />

Early responses of the lung to cigarette smoking<br />

Acute cough <strong>and</strong> bronchoconstriction are common reactions to the first inhalation of<br />

cigarette smoke. When this protective warning of the airways is ignored <strong>and</strong> regular<br />

smoking is begun, inflammatory changes appear in the small (>2 mm) airways of the<br />

lung. These changes are evident in some smokers within the first few years of smoking;<br />

<strong>and</strong>, after smoking for 10–15 years, the majority of smokers have evidence of abnormal<br />

function in these small airways. Much of the functional limitation of expiratory airflow<br />

in COPD results from increased resistance to expiratory airflow in these same small<br />

airways (Hogg et al. 1968). However, development of inflammatory changes in the<br />

small airways early in the smoking experience is not a useful predictor of the likelihood<br />

of subsequently developing clinically significant COPD. These early changes are likely a<br />

nearly universal response to the inhaled irritants in the smoke, <strong>and</strong> it is other biologic<br />

or genetic determinants of how the lung responds to chronic irritation that define<br />

which smokers will go on to develop COPD.<br />

Even during adolescence <strong>and</strong> early adulthood, cigarette smoking is associated with a<br />

lower level of lung function <strong>and</strong> an increased frequency of respiratory symptoms,<br />

particularly cough (USDHHS 1994). Adolescent smokers have a lower rate of increase<br />

in lung function as they grow into adulthood when compared to nonsmoking adolescents,<br />

<strong>and</strong> there is evidence that they reach a lower level of peak lung function (Tager<br />

et al. 1988). There is also concern that their decline in lung function may begin at an<br />

earlier age. Changes in lung development documented in actively smoking adolescents<br />

are likely superimposed on similar changes produced by exposure to environmental<br />

tobacco smoke during infancy <strong>and</strong> early childhood.<br />

Changes in lung function in smokers <strong>and</strong> nonsmokers<br />

DAVID M. BURNS<br />

The most widely used measure of lung function abnormality in COPD is the volume of<br />

air that can be expired during the first second with a maximal effort (FEV 1 ). Among<br />

populations of heavy smokers, an excess decline in the FEV 1 is first seen at age 25–34<br />

for both males <strong>and</strong> females in comparison with never smokers. An excess decline<br />

in FEV 1 is seen among both light <strong>and</strong> heavy smokers by age 35–44 (Beck et al. 1981).<br />

581

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!